Lv32
330 积分 2025-06-19 加入
Bispecific T cell engager therapy for refractory rheumatoid arthritis
7小时前
待确认
Defining immune reset: achieving sustained remission in autoimmune diseases
7小时前
已完结
Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti–tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: A randomized, placebo‐controlled, 52‐week trial
1天前
已完结
Efficacy of rituximab in systemic manifestations of primary Sjögren's syndrome: results in 78 patients of the AutoImmune and Rituximab registry
5天前
已完结
Adalimumab, a fully human anti–tumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: The ARMADA trial
8天前
已完结
Immunosuppression as a trigger for hyperinflammatory syndrome due to Strongyloides stercolaris in membranous nephropathy
8天前
已完结
Kidney Disease Associated with Schistosomiasis Mansoni
15天前
已完结
Injection site reactions with the use of biological agents
19天前
已完结
Type II Glycoengineered Anti-CD20 Antibody MIL62 or Cyclosporine in Chinese Primary Membranous Nephropathy: A Multicenter, Randomized, Open-Label Phase 1b/2 Trial
19天前
已关闭
Sibeprenlimab in IgA Nephropathy — Interim Analysis of a Phase 3 Trial
1个月前
已完结
嗜酸细胞性食管炎的诊治现状及进展
皖公网安备34019202002308
